Hugo RAS versus da Vinci Xi for robot-assisted simple hysterectomy in endometrial cancer: a concurrent-period comparison of operative efficiency, cost structure, and the cost of early adoption

Abstract Assessing a newly introduced robotic platform is complicated by structural confounding between platform and calendar time, which makes device-specific performance hard to separate from early-adoption learning. We compared the Hugo robotic-assisted surgery (RAS) system with the da Vinci Xi in robot-assisted simple hysterectomy for endometrial cancer, confining the primary analysis to the period of concurrent use of the two platforms. This single-centre retrospective cohort included 219 patients with clinical stage I endometrial cancer operated between May 2018 and November 2025; procedures involving lymphadenectomy or sentinel lymph node biopsy were excluded at eligibility so that operative time remained comparable. The Hugo RAS was introduced on 4 December 2023, and the standardised mean difference (SMD) for operative month across the full period was 2.10; the primary analysis was therefore limited to 67 concurrent-period procedures (da Vinci Xi 37, Hugo RAS 30; SMD 0.66). Time outcomes were modelled by linear regression and cost outcomes by gamma regression with a log link, both with robust standard errors. In the concurrent period, the adjusted mean difference in total operative time was 16.3 min (95% confidence interval [CI] 6.0–26.6; p = 0.002), falling to 6.1 min (95% CI − 0.7 to 13.0; p = 0.080) when the first ten Hugo RAS procedures were excluded. Adjusted cost ratios favoured the Hugo RAS for consumables (0.808) and total operative cost (0.923), with no clear difference in reimbursement (1.013). The attenuation after excluding early cases points to an early-adoption contribution that cannot be separated from platform effects.

Authors

Institutions

Publication Details

Journal
Journal of Robotic Surgery
Published
2026-11-16
DOI
https://doi.org/10.1007/s11701-026-04110-0
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hugo RAS versus da Vinci Xi for robot-assisted simple hysterectomy in endometrial cancer: a concurrent-period comparison of operative efficiency, cost structure, and the cost of early adoption

Takahiro Nozaki, Keiko Kagami, Ikuko Sakamoto, Yoshihiko Ito et al.
5 links
Journal of Robotic Surgery
Health Systems, Economic Evaluations, Quality of Life
article

Hugo RAS versus da Vinci Xi for robot-assisted simple hysterectomy in endometrial cancer: a concurrent-period comparison of operative efficiency, cost structure, and the cost of early adoption

Takahiro Nozaki, Keiko Kagami, Ikuko Sakamoto, Yoshihiko Ito, Naoki Fukada
article en

Abstract

Abstract Assessing a newly introduced robotic platform is complicated by structural confounding between platform and calendar time, which makes device-specific performance hard to separate from early-adoption learning. We compared the Hugo robotic-assisted surgery (RAS) system with the da Vinci Xi in robot-assisted simple hysterectomy for endometrial cancer, confining the primary analysis to the period of concurrent use of the two platforms. This single-centre retrospective cohort included 219 patients with clinical stage I endometrial cancer operated between May 2018 and November 2025; procedures involving lymphadenectomy or sentinel lymph node biopsy were excluded at eligibility so that operative time remained comparable. The Hugo RAS was introduced on 4 December 2023, and the standardised mean difference (SMD) for operative month across the full period was 2.10; the primary analysis was therefore limited to 67 concurrent-period procedures (da Vinci Xi 37, Hugo RAS 30; SMD 0.66). Time outcomes were modelled by linear regression and cost outcomes by gamma regression with a log link, both with robust standard errors. In the concurrent period, the adjusted mean difference in total operative time was 16.3 min (95% confidence interval [CI] 6.0–26.6; p = 0.002), falling to 6.1 min (95% CI − 0.7 to 13.0; p = 0.080) when the first ten Hugo RAS procedures were excluded. Adjusted cost ratios favoured the Hugo RAS for consumables (0.808) and total operative cost (0.923), with no clear difference in reimbursement (1.013). The attenuation after excluding early cases points to an early-adoption contribution that cannot be separated from platform effects.

Journal of Robotic SurgeryVol. 20(1)
Yamanashi Prefectural Central Hospital (JP)
Intuitive Foundation
Good health and well-being
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Hugo RAS versus da Vinci Xi for robot-assisted simple hysterectomy in endometrial cancer: a concurrent-period comparison of operative efficiency, cost structure, and the cost of early adoption — Takahiro Nozaki, Keiko Kagami, et al. · Journal of Robotic Surgery (2026) | TGRS Research Map | TGRS